The synovial fluids of patients with a destructive form of osteoarthritis (DOA) were shown to contain high levels of bone resorbing activity as judged by the ability of the fluid to stimulate the release of 45Ca from labelled cultured mouse calvariae. The activity was lost on extended storage of the synovial fluids and was dependent for its effect on cellular activity in bone. Bone resorbing activity was present in most synovial fluids from patients with DOA and rheumatoid arthritis (RA) but occurred at higher levels in the former. In contrast, interleukin 1 (IL1) activity, measured by the mouse thymocytes costimulation assay, was higher in RA than DOA synovial fluids. Little or no bone resorbing or ILl activity was detected in synovial fluids from patients with pseudogout or non-destructive osteoarthritis. These results suggest that most DOA synovial fluids contain a bone resorbing factor other than ILl. It is considered that the factor may be produced by synovial cells stimulated by hydroxyapatite crystals.
Osteoarthritis is a common disease characterised by destruction of articular cartilage with increased activity and remodelling of subchondral bone. A few patients have the disease in a more destructive form so that, in addition to extensive cartilage loss, there is radiological evidence of bone destruction. Clinical features in these patients may include pain, large cool effusions, and restriction of joint movement, with rapid progression of the destructive process. The synovial fluids of such patients are sterile and free from inflammatory cells, but they contain large amounts of hydroxyapatite crystals. Various names have been used to describe this destructive form of osteoarthritis (DOA), including apatite associated destructive arthropathy,1 Milwaukee shoulder syndrome,2 3 basic calcium phosphate crystal deposition disease,4 5 and analgesic arthropathy.6 7 The mechanisms of joint destruction in osteoarthritis are unknown, though some potential mediators have been investigated. Halverson 13 15
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It was noticed that SF appeared to have reduced bone resorbing activity on storage. To verify this observation samples were stored at -70°C and repeatedly thawed for each testing at intervals. Fig. 2 shows the result of experiment with three fluids. In each case there was a progressive loss of activity with time. In a further experiment (not illustrated) aliquots of the initial sample were obtained at the time of initial storage and only one sample thawed at each time. Activity again diminished with time, which suggests that the loss of activity is associated with length of time of storage rather than with the effect of repeated thawing and refreezing. Because of this all subsequent experiments on bone resorbing activity were conducted on fresh synovial fluids.
Experiments were set up to test the effect of varying the concentration of synovial fluid on bone resorbing activity. Synovial fluids with bone resorbing activity from patients with DOA were diluted and added to live labelled bones. Fig. 3 shows that there was stimulation of bone resorption at the lowest concentration tested, which was 1%. Peak resorption occurred at concentrations between 5% and 7%. At levels above 10% no further enhancement of calcium release was found; on the contrary, high concentrations inhibited bone resorption.
To test if the reduced effect at high concentrations of synovial fluid was due to a toxic effect on the cultured bone, high concentrations of SF were added to cultures stimulated with vitamin A.
Whereas the ratio of 45Ca released from vitamin A treated bones to that released from control bones was 1-6, the addition of 20% SF from patients with DOA reduced the ratio to less than 1 (complete inhibition). Suboptimal concentrations of SF (1-2%) had no effect on vitamin A induced 45Ca
release. Fig. 4 shows a comparison between the levels of bone resorbing activity in DOA synovial fluids and those in SF from other arthritides. High levels of activity were present in 24/25 of DOA synovial fluids, whereas little or no activity was detected in fluids from patients with OA and PA. Most (12/15) RA fluids were active, but the average level was significantly less than that found in DOA (p<0-05).
This could not be attributed to variations in the assay as the amount of 45Ca release induced by vitamin A, the positive control in these experiments, fell within the range shown for vitamin A in Fig. 1 . The possibility that this difference resulted from the RA fluids being tested at a suboptimal concen- Fig. 4 Comparison of bone resorbing activity in SFfrom different arthritides. Thefluids were tested at a final concentration of5%. The activity is expressed as the ratio of 45Ca releasedfrom treated bone to thatfrom bone in medium alone. The dotted line represents the upper limit of calcium release which is usually accepted as non-significant. tration was investigated by employing different concentrations of RA fluids. The results showed that, as with DOA, maximal activity occurred at a concentration of 6%. The three RA synovial fluids which were inactive in the initial test (Fig. 4) showed no activity at any of the dilutions tested.
HISTOLOGICAL EXAMINATION
The results recorded in Fig.. 1 tion. As a group rheumatoid fluids were significantly more active than those from patients with DOA (p<O-0l).
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DIALYSIS OF DOA SYNOVIAL FLUIDS
Preliminary experiments were set up to gain some insight into the chemical nature of the bone resorbing agent in DOA synovial fluids. DOA synovial fluids were tested before and after dialysis against medium for 48 hours at 4°C. The results showed that all synovial fluids had reduced bone resorbing activity after dialysis. In some (1-4) the activity was lost altogether, whereas in others (5 and 6) some activity still remained ( Table 2 ). The latter had detectable levels of ILl activity (greater than 10 000 cpm, see Fig. 7 ), whereas the former had insignificant levels (6000 cpm or less).
Discussion
The main conclusion from this study is that synovial fluid from patients with the rapidly destructive form of osteoarthritis contains one or more bone resorbing agents. The activity of the fluids was comparable in magnitude with that of other known bone resorbing agents such as vitamin A, ILl, and 
